Cutaneous Lupus Erythematosus (CLE)
Also known as: Cutaneous Lupus Erythematosus / Lupus Erythematosus, Cutaneous / Cutaneous lupus erythematosus (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16580 | Afimetoran | 1 | Completed | 1 |
| DB16391 | Daxdilimab | 1 | Completed | 1 |
| DB12943 | Milatuzumab | 1 | Completed | 1 |
| DB00523 | Alitretinoin | 2 | Terminated | 1 |
| DB18429 | Dazukibart | 2 | Recruiting | 1 |
| DB16242 | Dovramilast | 2 | Completed | 1 |
| DB00005 | Etanercept | 2 | Completed | 1 |
| DB14845 | Filgotinib | 2 | Completed | 1 |
| DB01677 | Fumaric acid | 2 | Completed | 1 |
| DB14770 | Lanraplenib | 2 | Completed | 1 |
| DB02701 | Nicotinamide | 2 | Active Not Recruiting | 1 |
| DB00864 | Tacrolimus | 2 | Completed | 1 |
| DB11976 | Anifrolumab | 3 | Not Yet Recruiting | 1 |
| DB00724 | Imiquimod | Not Available | Recruiting | 1 |
| DB00480 | Lenalidomide | Not Available | Completed | 1 |
| DB00337 | Pimecrolimus | Not Available | Withdrawn | 1 |